MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Prevelance,clinical pathology and Treatment of Dystonia in Pakistani Population

    S. Naureen, A. Arshad, N. Ahmad (RAWALPINDI, Pakistan)

    Objective:  Evaluate the gender,mean age,clinical spectrum and non–motor symptoms of the disease in Pakistan,a developing country of South East Asia. Background: Dystonia,a neurological syndrome,is characterized…
  • 2017 International Congress

    The Volatility of Local Field Potential Oscillations in Dystonia and Parkinson’s disease

    D. Pina Fuentes, J. van Zijl, J.-W. Elting, G. Drost, M. van Egmond, M. Oterdoom, M. Tijssen, M. van Dijk, M. Beudel (Groningen, Netherlands)

    Objective: To assess the volatility of low frequency (4-12Hz) and beta-band (13-30Hz) oscillations in local field potentials (LFPs) in dystonia and compare this to LFPs…
  • 2017 International Congress

    Substantial psychiatric symptoms, sleep disturbances and reduced quality of life in well-treated adult patients with GTP-cyclohydrolase deficient dopa-responsive dystonia

    A. Kuiper, E. Timmers, M. Smit, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study was to systematically investigate the prevalence of psychiatric disorders, sleep problems and health-related quality of life (HRQoL) in patients…
  • 2017 International Congress

    Clinical profile of patients with blepharospasm

    S. Kaleagasi, O. Dogu (Mersin, Turkey)

    Objective: To present the clinical profile of 61 patients with blepharospasm who were treated with onabotulinum toxin injections.  Background: Blepharospasm is a focal dystonia that…
  • 2017 International Congress

    Associations between Functional Networks and Temporal Discrimination Thresholds in Cervical Dystonia patients and their unaffected relatives

    S. Narasimham, V. Sundararajan, E. McGovern, B. Quinlivan, I. Beiser, R. Beck, S. Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: To investigate resting state functional networks across cervical dystonia patients and their unaffected relatives with and without abnormal temporal discrimination thresholds (TDTs) based on…
  • 2017 International Congress

    Impaired Pain Processing in Functional Dystonia

    F. Morgante, A. Matinella, E. Andrenelli, C. Allegra, C. Terranova, P. Girlanda, M. Tinazzi (Messina, Italy)

    Objective: Aim of the present study was to assess the sensory-discriminative and cognitive-emotional aspects of pain in patients with functional and idiopathic dystonia respectively assessing…
  • 2017 International Congress

    Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: In this study, it is aimed to analysis of clinical features and  treatment efficiency  in patients with servical dystonia who are performed Botulinum injection…
  • 2017 International Congress

    Determinants of health-related quality of life in children and young adults with dystonia

    H. Eggink, M. Coenen, A. Elema, W. Veenstra, K. Peall, D. Sival, M. Tijssen (Groningen, Netherlands)

    Objective: To systematically investigate to what extent motor and non-motor symptoms were related to health-related quality of life (HR-QoL) in children and young adults with…
  • 2017 International Congress

    Cognitive Function is Preserved 10 Years Following DBS in People with Dystonia

    E. Hogg, J. Eskenazi, E. During, J. Wertheimer, R. Alterman, M. Tagliati (Los Angeles, CA, USA)

    Objective: To study cognitive function in people with dystonia chronically treated with Deep Brain Stimulation (DBS). Background: The impact of DBS on cognition is a matter of…
  • 2017 International Congress

    Self-assessed psychological symptoms, fatigue and depersonalization in dystonia

    R. Newby, J. Alty, S. Jamieson, S. Smith, P. Kempster (Melbourne, Australia)

    Objective: To assess depressive, anxiety, fatigue and dissociative symptoms in patients with dystonia. Background: The basal ganglia, once considered exclusively concerned with motor control, are…
  • « Previous Page
  • 1
  • …
  • 1312
  • 1313
  • 1314
  • 1315
  • 1316
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley